Featured article

Preclinical safety analysis using Artificial Intelligence on the example of Alzheimer’s Disease.

Causaly AI enables researchers to identify safety-relevant information in medical literature regarding a drug candidate. Preclinical experts can include this data in the preclinical study design to minimize the risks of unforeseen toxicities and increase chances of approval.

Posts listed under Application

Sign up for Causaly newsletter